CL2012002092A1 -
Pharmaceutical composition comprising vx-222 and vx-950; where vx-950 improves the pharmacokinetics of vx -222; use in the treatment of hepatitis c.
- Google Patents
Pharmaceutical composition comprising vx-222 and vx-950; where vx-950 improves the pharmacokinetics of vx -222; use in the treatment of hepatitis c.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex PharmafiledCriticalVertex Pharma
Publication of CL2012002092A1publicationCriticalpatent/CL2012002092A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Método para mejorar los parámetros farmacocinéticos de VX-222 que comprende coadministrar VX-222 y VX-950; composición farmacéutica que comprende A) VX-222 de 20 Mg a 400 Mg y B) VX-950 de 100 Mg a 1500 Mg, útil para el tratamiento de un paciente infectado con HCV.Method for improving the pharmacokinetic parameters of VX-222 comprising co-administering VX-222 and VX-950; pharmaceutical composition comprising A) VX-222 of 20 Mg to 400 Mg and B) VX-950 of 100 Mg to 1500 Mg, useful for the treatment of a patient infected with HCV.
CL2012002092A2010-01-292012-07-27
Pharmaceutical composition comprising vx-222 and vx-950; where vx-950 improves the pharmacokinetics of vx -222; use in the treatment of hepatitis c.
CL2012002092A1
(en)
Compounds derived from 2'-substituted nucleosides, ns5a inhibitors; pharmaceutical composition that includes them; and its use in the treatment of hepatitis c.
Compounds derived from condensed nitrogen heterocycles, modulators of pi3k; pharmaceutical composition; and use in the treatment of a disease such as asthma, lupus, osteoarthritis, multiple sclerosis, cancer, among others.
Method for the treatment of hepatitis c (hcv) comprising administering a compound of formula (i), (ii) or (iii) in combination with one or more therapeutic agents; pharmaceutical composition
Compounds derived from 2,7-naphthyridines-1-one, mediators of syk; pharmaceutical composition; and use in the treatment of inflammatory, respiratory, cellular proliferative or autoimmune disease.
Indole-derived compounds [2,1-a] [2] benzacepin; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c.